Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
BackgroundThe appropriate age range for breast cancer screening remains a matter of debate. We aimed to estimate the effect of mammographic screening at ages 40–48 years on breast cancer mortality.MethodsWe did a randomised, controlled trial involving 23 breast screening units across Great Britain....
Uloženo v:
Hlavní autoři: | Stephen W. Duffy, Daniel Vulkan, Howard Cuckle, Dharmishta Parmar, Shama Sheikh, Robert A. Smith, Andrew Evans, Oleg Blyuss, Louise Johns, Ian O. Ellis, Jonathan P. Myles, Peter Sasieni, Sue Moss |
---|---|
Médium: | Artigo |
Jazyk: | angličtina |
Vydáno: |
2020
|
On-line přístup: | https://doi.org/10.1016/s1470-2045(20)30398-3 http://www.thelancet.com/article/S1470204520303983/pdf |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky
-
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
Autor: Duffy, Stephen W, a další
Vydáno: (2020) -
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
Autor: Duffy, Stephen, a další
Vydáno: (2020) -
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT
Autor: Stephen W. Duffy, a další
Vydáno: (2020) -
False-positive results in the randomised controlled trial of mammographic screening from age 40 (‘Age’ trial)
Autor: Johns, Louise E, a další
Vydáno: (2010) -
Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial
Autor: Sue Moss, a další
Vydáno: (2015)